BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

1st International mRNA Health Conference in Tubingen


8/16/2013 9:09:28 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Tübingen, Germany, 15 Aug. 2013 -- The 1st International mRNA Health Conference, taking place on Oct. 23 and 24, will be the first forum of its kind to host the world’s experts in mRNA. With this event, the conference organizers, which include the University of Tübingen, the University Hospital of Tübingen and the Tübingen-based biotechnology company CureVac, are laying the foundation for a new biotechnological sector: mRNA-based therapeutics. The conference is intended to become an annual event.

Medically used messenger RNA (mRNA) is currently evolving into a hotspot in research and development in biotechnology. A few years ago, the medical use of mRNA seemed almost out of reach. However, obstacles, such as the instability of the molecule, have now been overcome, and today, scientists around the world are developing drugs based on this highly potent biomolecule. The first clinical studies are currently ongoing, and innovative therapeutic treatment options for numerous diseases such as cancer, cardiovascular diseases or influenza are becoming more feasible. In October, experts in mRNA from academia and industry will present their latest study data to an expert audience, and a discussion of the medical potential of mRNA will follow.

The conference organizers, Michael Kormann, Ph.D., University of Tübingen, and Ingmar Hoerr, Ph.D., chief executive officer, CureVac, emphasize the special relevance of Tübingen to this event noting that nucleic acids, including RNA, were discovered here more than 140 years ago.

Further information about the 1st international mRNA Health Conference can be found under: http://www.mrna-conference.com

Contact:

Jun.-Prof. Dr. rer. nat. Michael Kormann

Universitätsklinik für Kinder- und Jugendmedizin (Abt. I)

Sektion Pädiatrische Infektiologie & Immunologie

AG Translationale Genomik und Gentherapie in der Pädiatrie

Wilhelmstr. 31

72074 Tübingen, Germany

Tel.: +49(0)7071/29-84305

Fax: +49(0)7071/29-4717

michael.kormann@med.uni-tuebingen.de

Verena Lauterbach

Manager Communications

CureVac GmbH, Tübingen, Germany

Tel.: +49(0)7071/92053-756

verena.lauterbach@curevac.com

Martina Schwarzkopf, Ph.D.

Account Supervisor

Russo Partners, LLC

12 West 27th Street, 4th Floor

New York, NY 10001

T (212) 845-4292

M (347) 591 8785

F (212) 845-4260

martina.schwarzkopf@russopartnersllc.com

www.russopartnersllc.com

Visit our blog at www.rxforpr.com.

Follow our agency and client news on Twitter. Sign up at www.twitter.com/russopartners

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES